Entreprise · 10/06/19941 min de lecture
The Use of Immunohistochemical Devices in the Clinical Care of Patients; Notice of Public Workshop
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing a public workshop to discuss the use of immunohistochemical devices in the clinical care of patients. In addition, FDA is interested in obtaining comments on the regulation of products used in immunohistochemical tests.